Maximal aerobic power, echocardiographical findings, and hemodynamic parameters.
ET subjects had 30% higher V˙O2peak than UT subjects. Similarly, ET subjects had a significantly larger LV cavity and thicker myocardial walls compared with those of the UT subjects. LV mass and SV were also significantly increased in ET, whereas ejection fraction and cardiac output did not differ between the groups. In contrast, LV work index was lower in the ET.
Resting HR was lower but systolic blood pressure was higher in the ET group than those in the UT group during the determination of basal MBF. Adenosine infusion increased the HR in both groups but did not have any significant effect on blood pressure. Blood pressure remained higher and HR remained lower in the ET group than those in the UT group during hyperemia (Tables 1 and 2).
The measured basal MBF was similar between the groups, but normalized (LV work index) basal MBF was significantly higher in the ET group than that in the UT group. During adenosine-induced hyperemia, both measured and MAP-normalized MBF were significantly lower and coronary vascular resistance was higher in the ET group than those in the UT group. MBF reserve determined using the normalized MBF values was significantly lower in the ET group than that in the UT group. We also calculated the whole LV wall blood flow by multiplying the measured MBF values with LV mass, and it was significantly higher in the resting state in the ET group than that in the UT group but similar between the groups during adenosine infusion. When age was used as a covariate, all significant differences remained. When LV mass/height2.7 was used as a covariate, normalized basal MBF was still significantly higher in the ET group than that in the UT group. However, measured and MAP-normalized hyperemic MBF and coronary vascular resistance were not different between the groups anymore. Because of significantly lower basal MBF, MBF reserve was still significantly lower in the ET group than that in the UT group despite this adjustment (Table 3).
Correlation between MBF and echocardiographical findings.
Table 4 shows the correlations between V˙O2peak, measured basal and hyperemic MBF, and different echocardiographical parameters in both groups combined and separately. Both groups combined, V˙O2peak correlated inversely with basal (P = 0.06) and hyperemic MBF (P < 0.01). V˙O2peak correlated positively with most of the structural echocardiographical parameters as well as LV mass, LV mass index, and LV mass/height2.7. Basal and hyperemic MBF correlated mainly negatively with the echocardiographical parameters. When age was used as covariate, all significant correlations with hyperemic MBF remained or became even stronger and most of those with basal MBF became significant (data not shown). On the other hand, when LV mass/height2.7 was used as partial correlate, the significant correlation between V˙O2peak and hyperemic MBF disappeared (r = −0.25, P = 0.10).
At the group level, V˙O2peak correlated negatively and significantly with basal MBF in the UT group and with hyperemic MBF in the ET group (Fig. 1). In addition, LV mass and LV mass index correlated similarly and negatively with basal MBF in both groups, although the only significant correlation was between basal MBF and LV mass index and LV mass/height2.7 in the ET group. In the ET group, this correlation seemed to be mainly due to increased LV cavity size and not with wall thickening because both basal and adenosine-stimulated MBF correlated significantly with LV diameter, but not with wall thickness, during diastole. When LV mass/height2.7 was used as a partial correlate, correlation between V˙O2peak and hyperemic MBF remained significant (r = −0.37, P = 0.047) and correlation between V˙O2peak and basal MBF in UT became even stronger (r = −0.59, P = 0.02).
MBF in subgroups of ET group.
Because indexed LV mass varied a lot within the ET group, we also compared the results within the three subgroups according to the LV mass/height2.7 (ET1 ≤ 60, n = 10; ET2 = 60–70, n = 12; ET3 > 70, n = 9). These subgroups did not differ from each other in any other demographic parameters, except that those in ET2 were older than those in the UT group and those in ET1 had lower BMI than those in the UT group. V˙O2peak did not differ significantly between ET groups (59 ± 4, 59 ± 4, and 63 ± 5 mL·g−1·min−1; P = 0.11). Because age and BMI differed between the groups, they were taken as covariates in ANCOVA in the following analyses. Normalized basal MBF was significantly higher in all ET subgroups than that in the UT group (UT, 0.58 ± 0.14; ET1, 0.87 ± 0.29; ET2, 0.89 ± 0.29; ET3, 0.83 ± 0.14; P < 0.02 between UT and ET subgroups). Correspondingly, normalized hyperemic MBF was significantly lower in all ET subgroups than that in the UT group (UT, 3.93 ± 1.36; ET1, 2.94 ± 0.68; ET2, 2.62 ± 1.25; ET3, 2.82 ± 0.66; P < 0.02 between UT and ET subgroups).
The present study was conducted to investigate the association between V˙O2peak and MBF in ET and UT subjects and whether the degree of LV hypertrophy associates to these variables. We found that ET males with significantly higher V˙O2peak had decreased hyperemic MBF compared with that of UT male subjects. Furthermore, we observed that this decreased hyperemic MBF was inversely related to LV mass and the difference between the groups disappeared when the LV mass differences were controlled for.
The ET subjects had an increased SV but similar ejection fraction and cardiac output at rest compared with those of UT subjects. These are normal and comparable findings with those of several earlier reports (36). In addition, the ET subjects demonstrated significantly increased wall thicknesses and, thereby, increased LV mass compared with those of the UT subjects. The average LV mass (330 g) and LV mass index (169 g·m−2) in trained subjects are among the highest values reported earlier (1,13). We also found a strong association between LV variables and V˙O2peak, as observed in earlier studies (1,36,41) when both groups were pooled together. In the subgroup analysis of the ET group, the trained subjects with the highest LV mass (or wall thickness) did not have superior V˙O2peak compared with that of the trained subjects with much lower mass. This indicates that pronounced myocardial hypertrophy is not a necessary adaptation to achieve a high V˙O2peak in trained subjects, as also suggested earlier (31), but has significant effect on myocardial vascular function, as suggested in the present study.
Basal MBF was similar in both groups, which is also in line with some (17,32,43) but not all previous investigations (13,18). We also observed that the total LV work was similar between the ET and UT subjects, but when LV work was normalized with LV mass (LV work index), the relative LV work was almost 40% lower in the ET group. However, although cardiovascular resistance is increased in athletes aiming to limit myocardial overperfusion (12,13) (oxygen supply vs demand), an athlete’s heart seems to be at least slightly luxuriously perfused at rest, as basal MBF normalized for LV work was significantly higher in athletes. This reasoning is based on the fact that LV work is normally closely coupled with oxygen consumption and myocardial perfusion.
During adenosine infusion, the ET group had, on average, 23% lower absolute hyperemic myocardial perfusion than that in the UT group. This is in accordance with the studies by Heiss et al. (47) and Heinonen et al. (13), whereas some other investigations have observed both unchanged (17,32) or increased (18,43) hyperemic perfusion in endurance athletes. We have previously shown an inverse relation between hyperemic MBF and exercise performance (maximal power output during cycling) in highly trained cross-country skiers with pronounced cardiac hypertrophy (13). In the present study, V˙O2peak was inversely related to hyperemic perfusion not only in the entire study population but also in the ET group alone. Moreover, when the group comparisons were also adjusted for age (Table 3), the results remained essentially similar. First, this observation suggests that endurance training diminishes the pharmacologically induced hyperemic blood flow. Second, it also highlights the importance of controlling for aerobic power when studying myocardial reactivity in healthy subjects. Indeed, when the association between V˙O2peak and hyperemic blood flow was controlled for LV mass, both the group difference and correlation (both groups combined) were not significant anymore. On the other hand, within the ET group, correlation remained significant despite this adjustment.
The major finding in the present study was that the ET group had significantly lower hyperemic MBF compared with that in the UT group. This finding is similar with that observed in many pathophysiological states, e.g., in hypertension (20) and in hypertrophic cardiomyopathy (HCM) (19), in which reduced hyperemic MBF or perfusion reserve has been observed (4,22). In addition, our observation of higher perfusion resistance in ET subjects during hyperemic conditions is in line with the results from Knaapen et al. (19), as performed with HCM patients. This suggests that the reduced hyperemic MBF is due to higher extravascular compressive forces. Because many anatomical changes in HCM are similar with those observed in athlete’s heart (6), one can hypothesize that these changes would also be related to decreased perfusion reserve in ET subjects. In this regard, we found a trend toward a lower reserve in ET men, as measured in absolute terms. When the blood flow reserve was calculated as a ratio between MAP-normalized hyperemic and work-normalized basal blood flow, ET subjects demonstrated almost 50% lower reserve. Consequently, the alteration in hyperemic MBF in ET subjects with very pronounced LV hypertrophy may also have physiological or even clinical significance, but further research is warranted to investigate this possibility.
Mechanistically, it has been suggested that the reduced capillary density, which accompanies the increased LV mass, induces microvascular dysfunction in HCM (21,37). Myocardial perfusion measures, especially during hyperemia as also determined in the present study, serve as a noninvasive functional surrogate for capillary density (4). Studies in healthy animals have proposed that endurance training leads to increased density of coronary arterioles (3,46), whereas capillary density remains largely unchanged (3,26) when cardiac hypertrophy remains minor. However, capillary density can also be decreased even in healthy animals when training has induced marked cardiac hypertrophy (3,46). Furthermore, although the size of coronary arteries is usually closely associated to the LV mass in healthy humans (9), evidence that the growth or enlargement of coronary vasculature does not necessarily always follow the rate of increase in myocardial mass exists (34), which may explain the finding of decreased hyperemic blood flow with increasing LV mass in the present study.
Importantly, rather than associated with the so-called concentric hypertrophy that is typical for many pathophysiological cardiac diseases such as hypertension, we found here that decreased hyperemic blood flow correlated negatively with variables that depict eccentric hypertrophy (larger cavity dimension) and not, for example, with RWT that is a good marker of concentric hypertrophy. Eccentric hypertrophy is a very typical feature for athletes exposed to high-volume loads during their training, like our trained subjects. Eccentric hypertrophy may also be associated with decrease in capillary length density, which is also known to occur as a result of training, leading to cardiac hypertrophy (3). However, although increasing exercise hyperemia pharmacologically has been shown to improve cardiac function (11) and oxygen consumption (16) at near-maximal exercise, our findings do not necessarily mean that athletes with very pronounced hypertrophy are compromised in their cardiac pumping function, let alone experience ischemia even at maximal exercise. The ET subjects we studied reported having never experienced any chest pain or related sensations. In addition, many of them had succeeded well in international competitions such as in different world championships. Accordingly, it seems that despite reduced cardiac hyperemic vasodilator reserve, LV hypertrophy does not lead to greater susceptibility to myocardial ischemia during external stress (27), but fine-tuned regulatory pathways are able to control bodily function so that capacities of any organ are not exceeded even at maximal exertion (28–30).
Finally, in line with our finding of impaired pharmacologically induced hyperemic response, it has also been previously reported that coronary artery blood flow response to reactive hyperemia is decreased in vigorously trained dogs (42). Reactive hyperemia is a widely used procedure also in human peripheral arteries, correlating positively with fitness in healthy but UT subjects (33,39). However, exercise training has been shown to cause dissociation between peripheral flow capacity and maximal aerobic power (14). Thus, these earlier findings and our results strongly support the proposition of “athlete’s paradox” in which highly trained and performing athletes can have even decreased hyperemic responses when assessed by standard determination procedures at resting state (10).
Taken together, the present study supports the findings from the peripheral vasculature of ET subjects that the cardiac vasodilatory capacity is also not improved but can even be reduced, compared with that in UT controls. In particular, MBF during adenosine-induced hyperemia is diminished in ET subjects and this decrease is associated to V˙O2peak, and especially the degree of LV hypertrophy.
We thank the personnel in the Turku PET Centre for their help with the PET studies.
This study was supported by grants from the Finnish Cultural Foundation and the Ministry of Education and Culture (Finland).
M. S. L. and I. H. contributed equally to the study.
The authors declare no conflict of interest.
The results of the present study do not constitute endorsement by the American College of Sports Medicine.
1. Barbier J, Lebiller E, Ville N, Rannou-Bekono F, Carre F. Relationships between sports-specific characteristics of athlete’s heart and maximal oxygen uptake. Eur J Cardiovasc Prev Rehabil
. 2006; 13 (1): 115–21.
2. Batterham A, George KP, Whyte G, Sharma S, McKenna W. Scaling cardiac structural data by body dimensions: a review of theory, practise, and problems. Int J Sports Med
. 1999; 20 (8): 495–502.
3. Breisch EA, White FC, Nimmo LE, McKirnan MD, Bloor CM. Exercise-induced cardiac hypertrophy: a correlation of blood flow and microvasculature. J Appl Physiol (1985)
. 1986; 60 (4): 1259–67.
4. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med
. 2007; 356 (8): 830–40.
5. Chan SY, Brunken RC, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol
. 1992; 20 (4): 979–85.
6. Cheng TO. Hypertrophic cardiomyopathy vs athlete’s heart. Int J Cardiol
. 2009; 131 (2): 151–5.
7. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol
. 1986; 57 (6): 450–8.
8. Dewey FE, Rosenthal D, Murphy DJJ, Froelicher VF, Ashley EA. Does size matter? Clinical applications of scaling cardiac size and function for body size. Circulation
. 2008; 117 (17): 2279–87.
9. Dodge JTJ, Brown BG, Bolson EL, Dodge HT. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation
. 1992; 86 (1): 232–46.
10. Green DJ, Spence A, Rowley N, Thijssen DH, Naylor LH. Vascular adaptations in athletes: is there an ‘athlete’s artery’? Exp Physiol
. 2012; 97 (3): 295–304.
11. Gwirtz PA, Dodd-o JM, Brandt MA, Jones CE. Augmentation of coronary flow improves myocardial function in exercise. J Cardiovasc Pharmacol
. 1990; 15 (5): 752–8.
12. Haskell WL, Sims C, Myll J, Bortz WM, St Goar FG, Alderman EL. Coronary artery size and dilating capacity in ultradistance runners. Circulation
. 1993; 87 (4): 1076–82.
13. Heinonen I, Nesterov SV, Liukko K, et al. Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men. J Physiol
. 2008; 586 (Pt 21): 5193–202.
14. Hepple RT, Babits TL, Plyley MJ, Goodman JM. Dissociation of peak vascular conductance and V(O2) max among highly trained athletes. J Appl Physiol (1985)
. 1999; 87 (4): 1368–72.
15. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med
. 1995; 36 (1): 78–85.
16. Ishibashi Y, Zhang J, Duncker DJ, Klassen C, Pavek T, Bache RJ. Coronary hyperperfusion augments myocardial oxygen consumption. Am J Physiol
. 1996; 271 (4 Pt 2): H1384–93.
17. Kalliokoski KK, Nuutila P, Laine H, et al. Myocardial perfusion and perfusion reserve in endurance-trained men. Med Sci Sports Exerc
. 2002; 34 (6): 948–53.
18. Kjaer A, Meyer C, Wachtell K, et al. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy. Am J Cardiol
. 2005; 96 (12): 1692–8.
19. Knaapen P, Germans T, Camici PG, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol
. 2008; 294 (2): H986–93.
20. Kozakova M, de Simone G, Morizzo C, Palombo C. Coronary vasodilator capacity and hypertension-induced increase in left ventricular mass. Hypertension
. 2003; 41 (2): 224–9.
21. Krams R, Kofflard MJ, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation
. 1998; 97 (3): 230–3.
22. Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol
. 1998; 32 (1): 147–53.
23. Laughlin MH. Effects of exercise training on coronary transport capacity. J Appl Physiol (1985)
. 1985; 58 (2): 468–76.
24. Laughlin MH, Bowles DK, Duncker DJ. The coronary circulation in exercise training. Am J Physiol Heart Circ Physiol
. 2012; 302 (1): H10–23.
25. Laughlin MH, Overholser KA, Bhatte MJ. Exercise training increases coronary transport reserve in miniature swine. J Appl Physiol (1985)
. 1989; 67 (3): 1140–9.
26. Laughlin MH, Tomanek RJ. Myocardial capillarity and maximal capillary diffusion capacity in exercise-trained dogs. J Appl Physiol (1985)
. 1987; 63 (4): 1481–6.
27. Massie BM, Schaefer S, Garcia J, et al. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation
. 1995; 91 (6): 1814–23.
28. Noakes TD. Physiological models to understand exercise fatigue and the adaptations that predict or enhance athletic performance. Scand J Med Sci Sports
. 2000; 10 (3): 123–45.
29. Noakes TD. Fatigue is a brain-derived emotion that regulates the exercise behavior to ensure the protection of whole-body homeostasis. Front Physiol
. 2012; 3 (82): 82.
30. Noakes TD, St Clair Gibson A. Logical limitations to the “catastrophe” models of fatigue during exercise in humans. Br J Sports Med
. 2004; 38 (5): 648–9.
31. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med
. 1991; 324 (5): 295–301.
32. Radvan J, Choudhury L, Sheridan DJ, Camici PG. Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy. Am J Cardiol
. 1997; 80 (12): 1621–3.
33. Reading JL, Goodman JM, Plyley MJ, et al. Vascular conductance and aerobic power in sedentary and active subjects and heart failure patients. J Appl Physiol (1985)
. 1993; 74 (2): 567–73.
34. Roberts JR, Wearn JI. Quantitative changes in the capillary muscle relationship in human hearts during normal growth and hypertrophy. Am Heart J
. 1941; 21: 617–33.
35. Rowley NJ, Dawson EA, Hopman MT, et al. Conduit artery and wall remodelling in elite athletes and spinal cord injury. Med Sci Sports Exerc
. 2012; 44 (5): 844–9.
36. Scharhag J, Schneider G, Urhausen A, Rochette V, Kramann B, Kindermann W. Athlete’s heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol
. 2002; 40 (10): 1856–63.
37. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol
. 1998; 31 (5): 1089–96.
38. Sipilä H, Clark JC, Peltola O, Teräs M. An automatic [15
O production system for heart and brain studies. J Labelled Compd Rad
. 2001; 44: S1066–8.
39. Snell PG, Martin WH, Buckey JC, Blomqvist CG. Maximal vascular leg conductance in trained and untrained men. J Appl Physiol (1985)
. 1987; 62 (2): 606–10.
40. Spence AL, Naylor LH, Carter HH, et al. A prospective randomised longitudinal MRI study of left ventricular adaptation to endurance and resistance exercise training in humans. J Physiol
. 2011; 589 (Pt 22): 5443–52.
41. Steding K, Engblom H, Buhre T, et al. Relation between cardiac dimensions and peak oxygen uptake. J Cardiovasc Magn Reson.
2010; 12 (8): 8.
42. Stone HL. Coronary flow, myocardial oxygen consumption, and exercise training in dogs. J Appl Physiol Respir Environ Exerc Physiol
. 1980; 49 (5): 759–68.
43. Toraa M, Pouillard F, Merlet P, Friemel F. Cardiac hypertrophy and coronary reserve in endurance athletes [in French]. Can J Appl Physiol
. 1999; 24 (1): 87–95.
44. Utomi V, Oxborough D, Whyte GP, et al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete’s heart. Heart
. 2013; 99 (23): 1727–33.
45. White FC, Bloor CM, McKirnan MD, Carroll SM. Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol (1985)
. 1998; 85 (3): 1160–8.
46. White FC, McKirnan MD, Breisch EA, Guth BD, Liu YM, Bloor CM. Adaptation of the left ventricle to exercise-induced hypertrophy. J Appl Physiol (1985)
. 1987; 62 (3): 1097–110.
47. Heiss HW, Barmeyer J, Wink K, et al. Studies on the regulation of myocardial blood flow in man. I.: Training effects on blood flow and metabolism of the healthy heart at rest and during standardized heavy exercise. Basic Res Cardiol
. 1976; 71: 658–75.
Keywords:© 2014 American College of Sports Medicine
HEART; PERFUSION; ENDURANCE TRAINING; POSITRON EMISSION TOMOGRAPHY